Mammoth Biosciences
Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are designed to be more specific and enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, reverse transcriptase editing, and epigenetic editing.Our company is building out its wholly owned pipeline of potential in vivo gene ed
Basic Information
- Category: Gene Editing
- Founded: 2017
- Headquarters: South San Francisco, CA
- Website: mammoth.bio
Documented Facts
- Email: info@mammothbiosci.com (No linked source recorded for this statement.)
- CEO: of Mammoth Biosciences (No linked source recorded for this statement.)
- Country: Our (No linked source recorded for this statement.)
Evidence and Sources
- Mammoth Biosciences — Official Site (official)
- Mammoth Biosciences on linkedin (social)
Citation Guidance
Explore Gene Editing profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Mammoth Biosciences.
- Canonical profile: https://brandsource.ai/brands/mammoth-biosciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/mammoth-biosciences/json-ld
- Citation profile API: https://brandsource.ai/api/brands/mammoth-biosciences/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (87/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:06.091Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are designed to be more specific and enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, reverse transcriptase editing, and epigenetic editing.Our company is building out its wholly owned pipeline of potential in vivo gene ed
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.